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Abstract
Background: The Scar/WAVE family of proteins mediates signals to actin assembly by direct
activation of the Arp2/3 complex. These proteins have been characterised as major regulators of
lamellipodia formation downstream of Rac activation and as members of large protein complexes.
Results: We have investigated the interactions of the three human Scar/WAVE isoforms with
several previously described binding partners for Scar/WAVE 1 or 2. We find that all three Scar/
WAVE isoforms behave similarly and are likely to participate in the same kinds of protein
complexes that regulate actin assembly.
Conclusion: Differences between Scar/WAVE proteins are therefore likely to be at the level of
tissue distribution or subtle differences in the affinity for specific binding partners.
Background
Rearrangements of the cortical actin cytoskeleton are
essential for numerous cell processes such as cell migra-
tion, phagocytosis [1,2], and adhesion [3], in which for-
mation of dendritic networks of polymerised actin plays a
key part. The Arp2/3 complex is required in the formation
of dendritic networks to provide sites for de novo nuclea-
tion of actin filaments and to form branch points from
existing filaments [4-6]. The mammalian Arp2/3 complex
can be activated downstream of Rho family small GTPases
by several known interacting proteins, in particular mem-
bers of the Wiskott Aldrich Syndrome Protein Family
(haematopoietic WASP, ubiquitous N-WASP, and Scar/
WAVE 1, 2, and 3 [Suppressor of Cyclic AMP Receptor
mutation/Wiskott Aldrich VErprolin homologous pro-
tein]) [7,8]. Homology between these proteins consists of
a core proline rich region, and C-terminal WH2 (Wiskott
Homology 2) and Acidic (A) domains, of which the WH2
and A domains together are sufficient to activate the Arp2/
3 complex [9-11]. N-WASP and the Scar/WAVE proteins
differ the most at the amino-terminus, designated the
Wiskott-Homology 1 (WH1) domain and the Scar/WAVE
homology domain (SHD) [9].
Regulation of WASP-family proteins involves many inter-
actions and is still the subject of intensive research. WASP
and N-WASP are found in an inhibitory complex with
WIP/CR16 proteins and can be activated by the small
GTPase Cdc42 and a co-activating protein TOCA-1,
recently described by Ho et al. [12]. Phosphorylation on
tyrosine residues in the N-terminal half of WASP/N-WASP
can also enhance the activation and perhaps serve to pro-
long its duration ([13-15]). Original reports had sug-
gested that WASP/N-WASP were autoinhibited in their
pure form, but whether this form is ever present in cells is
unclear, so the physiological relevance of autoinhibition
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is unclear as well ([16]). Recombinant Scar/WAVE pro-
teins were constitutively active toward Arp2/3 complex in
vitro, but have been postulated to be regulated by the
small GTPase Rac in vivo [17,18]. In 2002, Eden et al puri-
fied Scar/WAVE1 from bovine brain extracts in association
with a complex of four other proteins; p140-SRA1, p125
Nck-Associated Protein (NckAP1), HSPC300, and Abi2
[19]. They proposed a model whereby active Rac could
bind to p140-SRA1 and cause it plus NckAP1 and Abi2 to
dissociate, releasing active Scar/WAVE in a complex with
HSPC300.
Some of the members of this so-called "Scar/WAVE com-
plex" had been previously studied by other groups and
implicated in signalling. SRA1 (also called Cytoplasmic
FMRP Interacting protein [20]) is a Rac associated protein
which also binds to the SH3 domain containing adapter
protein Nck, and the Fragile-X Mental Retardation Protein
(FMRP) [20-23]. NckAP1 also interacts with active Rac
and Nck, although the interaction appears to be indirect
in both cases [22,23]. HSPC300 is a small, ubiquitously
expressed, uncharacterised Haematopoeitc Stem/Progeni-
tor Cell protein, bearing considerable homology to the
Maize actin cytoskeletal associated protein Brk1 [24-26].
Abi2 (Abl interactor 2) is a neuronally expressed SH3
domain containing protein associated with Abl tyrosine
kinase [27]. It has a close relative, Abi1, also referred to as
e3B1 (eps8 binding protein 1) in early literature [28,29].
Since Eden et al., a similar complex has also been isolated
in association with Scar/WAVE2 [30,31]. This complex
contains the more ubiquitously expressed Abi1 (as
opposed to Abi2) consistent with the more ubiquitous
expression of Scar/WAVE 2 compared to the other Scar/
WAVE isoforms [31-33]. In these studies, the complex
does not dissociate upon Rac activation and is not inhibi-
tory during in vitro actin polymerisation assays [31].
Recombinant Abi1 is rather found to increase the Arp2/3
complex activating ability of recombinant Scar/WAVE 2
[31]. Following these studies, the mechanism for regula-
tion of the different Scar/WAVE proteins has been called
into question. It has been proposed that differences
between Eden et al. and the other two studies may be due
to experimental conditions or to genuine differences
between Scar/WAVE isoforms [19,30,31,34,35].
Knockdown of Abi1, SRA1 and NckAP1 in mammalian
tissue culture cells causes severe defects in formation of
lamellipodia [31,36], similar to loss of Scar/WAVE 2 activ-
ity [37,38]. Mutations or RNAi knockdown of the only
Drosophila Scar/WAVE protein severely affects the ability
of cultured cells to produce lamellipodia, ruffles and filo-
podia [39-41]. Mutational and RNAi studies used to pro-
duce Drosophila cells deficient in the NckAP1 homologue,
Kette, reveal a lack of actin based protrusions in the
absence of functional protein [42,43]. RNAi knockdown
of Drosophila Abi1 and SRA1 also prevents the formation
lamellipodia in tissue culture cells [39,41,43]. Dictyostel-
ium knock out of Scar protein exhibits severe defects in
chemotaxis and motility, but cells can still extend pseudo-
pods and migrate directionally [44,45], whereas knockout
of the PirA gene encoding an homologue of SRA1 causes
an excessive lamellipodial protrusion phenotype, thought
to be due to unregulated Scar protein activity [46].
While the Scar/WAVE complex is currently thought to be
the most likely regulator of Scar/WAVE activity in cells,
several other Scar/WAVE binding proteins have been iden-
tified and proposed to regulate its activity. IRSp53, for
example, binds to Scar/WAVE2 and also to Rac and was
proposed to be a Scar/WAVE2 regulator prior to Eden et
al. ([47-50]). It was unclear whether IRSp53 binding was
specific to Scar/WAVE 2, or ubiquitous among the Scar/
WAVEs and where/when Scar/WAVE was associated with
IRSp53 as opposed to the other binding partners. IRSp53
is also a scaffold protein, with several partners, raising the
possibility of at least two different types of large protein
complexes in association with Scar/WAVE proteins
[49,51-55].
Scar/WAVE3 is the most tissue-specific of the three mam-
malian Scar/WAVE isoforms, being found in haematopoi-
etic cells and brain tissue, but not yet being characterised
in cells [9,56]. It has not previously been shown whether
Scar/WAVE3 interacts with either Abi1/2 or HSPC300.
This report presents data indicating that the interaction of
Scar/WAVE proteins with Abi1, HSPC300 and IRSp53 is
conserved among all three Scar/WAVE proteins, suggest-
ing that multiple different protein complexes likely exist
in cells that contain different Scar/WAVE isoforms. This
observation suggests that the different Scar/WAVE iso-
forms are not regulated by exclusive participation in spe-
cific complexes, but rather that the regulation is likely to
be more subtle, at the level of affinity or modifications/
binding partners not yet discovered. Alternatively, Scar/
WAVEs may have largely overlapping functions when
present in the same cell type, although there is already
some evidence against this idea [57].
Results
Association of the Scar/WAVE complex with Scar/WAVE 3
Protein sequence conservation between the three Scar/
WAVE proteins in the N-terminal Scar Homology Domain
(SHD) indicates a potential for association of binding
partners with all three members of the family. Scar/
WAVE1 and 2 have been shown to associate with the key
adapter protein Abi1 through the SHD, so it is possible
that Abi1 would also associate with Scar/WAVE3 [19,30].
To test for an interaction between Scar/WAVE3 and Abi1,
immunoprecipitations were performed with antibodiesBMC Cell Biology 2005, 6:11 http://www.biomedcentral.com/1471-2121/6/11
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recognising Abi1 (Fig. 1A) and antibodies recognising
Scar/WAVE3 (Fig. 1B). Anti-Abi1 immunoprecipitates co-
precipitate Scar/WAVE1 and 3 with endogenous Abi1
from mouse brain extracts, while Abi1, Scar/WAVE1 and
Scar/WAVE3 are not present in immunoprecipitates with
an unrelated control antibody or without antibody (Fig.
1A). Abi1 also co-immunoprecipitates with Scar3, but is
not detected in the absence of antibody or in unrelated
control immunoprecipitates (Fig. 1B). Since Abi1 is
thought to bind directly to Scar/WAVE proteins and to
connect them with the rest of the Scar/WAVE complex,
interaction with Abi1 is a strong indicator Scar/WAVE3
Co-immunoprecipitation of Scar3 and Abi1 from mouse brain extract Figure 1
Co-immunoprecipitation of Scar3 and Abi1 from mouse brain extract. Protein G beads were used to precipitate Abi1 from 
mouse brain extracts in the presence or absence of (A) anti-Abi1 or an unrelated control antibody or (B) anti-Scar3 or an 
unrelated control antibody. (A) The beads fractions were probed with anti-Abi1, anti-Scar/WAVE1 and anti-Scar/WAVE3. 
Anti-Abi1 immunoblotting confirmed precipitation of Abi1 only with specific antibody and immunoblotting with anti-Scar/
WAVE1 shows association with a known binding partner. Immunoblotting with anti-Scar/WAVE3 revealed Scar/WAVE3 to 
also be present in Abi1 immunoprecipitates. Anti-Abi1 pulls down both Scar1 and Scar3 together with Abi1. (B) Beads fractions 
from anti-Scar/WAVE3 immunoprecipitates were probed with both anti-Scar/WAVE3 and anti-Abi1. Both Scar3 and Abi1 are 
detected in anti-Scar/WAVE3 immunoprecipitates, but not with controls.
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associates in an analogous complex to Scar/WAVE1 and 2
isoforms [35].
Conservation of Scar complex association between all 
three human Scar/WAVE isoforms
Our data and previously published studies indicate that
Abi1 exhibits the potential to bind to all three mamma-
lian Scar/WAVE isoforms. To test whether the association
of Scar/WAVE1, 2, and 3 with Abi1 is mediated by the Scar
Homology Domain, Myc-Scar/WAVE SHD of each of the
three family members were transiently expressed in Cos
cells with HA-Abi1 or HA-HSPC300 and immunoprecipi-
tated using a 9E10 anti-myc monoclonal antibody. HA-
Abi1 precipitated with each of the three SHDs, but not in
the absence of antibody or Myc-SHD (Fig. 2A). HA-
Co-immunoprecipitation of Abi1 and HSPC300 with Scar  Homology Domain Figure 2
Co-immunoprecipitation of Abi1 and HSPC300 with Scar 
Homology Domain. Cos 7 fibroblasts transiently transfected 
as indicated. Protein G beads were used to immunoprecipi-
tate Myc-Scar1 SHD, Myc-Scar2 SHD or Myc-Scar3 SHD 
from lysates in the presence (+) or absence (-) of anti-Myc 
(9E10) monoclonal antibody. Empty pRK5-Myc vector was 
used as an additional negative control. (A) HA-Abi1 was 
detected in the beads plus antibody fractions for Myc-Scar1 
SHD, Myc-Scar2 SHD, and Myc-Scar3 SHD, but not in the 
negative controls. (B) HA-HSPC300 was detected in the 
beads plus antibody fraction of immunoprecipitations from 
cells co-transfected only with Myc-Scar1 SHD, Myc-Scar2 
SHD, and Myc-Scar3 SHD, but not empty vector controls or 
in the absence of 9E10 antibody.
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Recombinant SHD pulls down Abi1 and HSPC300 Figure 3
Recombinant SHD pulls down Abi1 and HSPC300. Lysate of 
Cos7 fibroblasts transfected with HA-Abi1 or HSPC300 was 
incubated as indicated with GST alone, GST-Scar1 SHD (A), 
GST-Scar2 SHD (A), or GST-Scar3 SHD (B) on glutathione-
s-agarose beads. Beads bound fractions were analysed by 
SDS-PAGE and immunoblotting with a monoclonal anti-Myc 
(9E10) antibody. HA-Abi1 and HA-HSPC300 were found in 
pull-downs with all three Scar Homology Domains, but not 
with GST alone.
Table 1: Yeast two-hybrid analysis of interactions between Abi1, 
HSPC300, and various domains of Scar1. (+) Indicates a positive 
interaction backed up by a beta-Gal reporter gene assay. (-) 
Indicates negative for an interaction between the constructs.
pAct-Scar1 PYTH9
HSPC300 Abi1
Full Length (FL) + +
SB + +
SP + +
BPWA - +/-
PWA - -
GST
GST-Scar2 SHD
Myc-Abi1
Myc-HSPC300
GST-Scar1 SHD
++
++
++
+ + +
+ + +
- - - -
- - - -
-
---
--
- - - -
Anti-Myc
Immunoblot
GST
GST-Scar3 SHD
+
-
-
-
-
+
+
+
Myc-Abi1
Myc-HSPC300
++
++
- -
- -
A
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HSPC300 also co-immunoprecipitated with all three
SHDs, but not the negative controls (Fig 2B). Pull-down
experiments performed from HA-Abi1 or HA-HSPC300
transfected Cos cell lysates using GST-fusion proteins of
Scar/WAVE1 and 2 (Fig. 3A) and Scar/WAVE3 (Fig. 3B)
also show conservation of interaction of all human Scar/
WAVE isoforms with Abi1 and HSPC300. Supporting data
showing the specific interaction of Abi1 with Scar/WAVE1
SHD is shown in Table 1 and Additional file 1B. Data sup-
porting interaction of Scar/WAVE1 SHD with HSPC300 is
shown in Table 1 and in Additional file 1C.
Conserved interaction of Scar/WAVE isoforms with IRSp53
Conservation of Scar Homology Domain binding part-
ners raises the question of whether other binding partners
of Scar/WAVE are also capable of interacting with the
entire Scar/WAVE family. IRSp53 has been implicated in
regulation of actin dynamics through binding to Scar/
WAVE proteins [49,50,54]. GST-IRSp53 was used for pull
down experiments to test for binding to Scar/WAVE1, 2,
and 3 (Fig. 4). None of the Scar/WAVE isoforms were
detected in the beads fraction of a negative control (con-
stitutively active GST-L61 Cdc42), but all were detected in
the beads fraction of GST-IRSp53. An ability to bind to
IRSp53 is conserved between all three human members of
the Scar/WAVE family, although the binding appears to be
strongest for Scar/WAVE2. Conservation of this interac-
tion may indicate that all three Scar/WAVE proteins are
regulated by common mechanisms, but the increased
binding of Scar/WAVE2 to IRSp53 highlights the possibil-
ity that differing affinities for binding partners between
the three Scar/WAVE isoforms may affect their roles in
cells.
Cellular localisation of Scar/WAVE3
As an activator of the Arp2/3 complex, Scar/WAVE3
would be expected to localize to the same areas of the cell
as polymerized actin, subunits of the Arp2/3 complex,
and members of the Scar/WAVE complex. C2C12 cells
were used for immunocytochemistry with anti-Scar3 pol-
yclonal antibody (Fig. 5Ai, Bi, Ci), phalloidin to detect fil-
amentous actin (Fig. 5Aii), anti-Arp2/3 monoclonal
antibody (Fig. 2Bii), and anti-Abi1 antibody (Fig. 5Cii).
C2C12 cells were used because they were the only stand-
ard tissue culture cell line that we found to contain a
detectable amount of Scar/WAVE3 protein (see Methods).
Scar/WAVE3 mainly exists in a peri-nuclear pool with
enrichment to areas of polymerised actin (Fig. 5Aiii).
Scar/WAVE3 co-localises with the Arp2/3 complex subu-
nit, Arp3 (Fig. 5Biii), and with Abi1 (Fig. 5iii) in areas of
IRSp53 interacts with Scar/WAVE1, 2 and 3 Figure 4
IRSp53 interacts with Scar/WAVE1, 2 and 3. Equivalent amounts of GST-IRSp53 or constitutively active GST-L61 Rac were 
used for pull-down assays from lysates of Cos cells transfected with Myc-Scar1, 2 or 3. Bead fractions and whole cell lysates, 
indicating loading with each Scar/WAVE isoform, were analysed by SDS-PAGE and immunoblotting with monoclonal (9E10) 
anti-Myc antibody. None of the Scar/WAVE isoforms bound to active Cdc42, but all were detected in GST-IRSp53 bead 
fractions.
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lamellipodial protrusion. Our results show Scar/WAVE3
to localise to areas of polymerised actin near the cell
periphery and to co-localise with a known component of
the Scar/WAVE complex, indicating that Scar/WAVE3 may
have a similar role and method of regulation to Scar/
WAVE1 and 2.
Cellular localisation of Scar/WAVE SHD, Abi1, and 
HSPC300
If the SHD of Scar/WAVE protein mediates the interaction
with a regulatory complex it can be expected that the SHD
will co-localise with binding partners in cells. Ectopic
expression of full length Scar/WAVE isoforms in cells
reveals a peri-nuclear and cytoplasmic pool, causing an
abundance of polymerised actin in the cytoplasm, but
with enrichment of Scar/WAVE protein in lamellipodia
[50,58]. A sizeable amount of Myc-Scar 1 SHD (Fig 6Aiii),
Myc-Scar 2 SHD (Fig 6Aiv), and Myc-Scar 3 SHD (Fig.
6Av) localises to the cell periphery in lamellipodia, as well
as in a cytoplasmic pool similar to full length Scar/WAVE
proteins (see Figure 5Ai for comparison). HA-Abi1 is
present throughout the cytoplasm in spots (Fig 6Aii), pre-
viously described as characteristic of the reticulovesicular
system [59]. HA-HSPC300 exhibits a similar cellular
localisation to ectopically expressed Scar/WAVE1, 2 and 3
being abundant in and around the nucleus, and diffusely
around the cytoplasm with enrichment at lamellipodia
(Fig 6Ai).
When expressed with Myc-Scar 1 SHD (Fig. 6Bi), HA-
HSPC300 (Fig. 6Bii) co-localises (Shown as yellow in
merge pictures [6Biii]) with enrichment in ruffles. Myc-
Scar/WAVE 2 (Fig. 6Di), and 3 (Fig 6Fi) SHD also co-
localises with HA-HSPC300 (Fig. 6Dii, 6Fii) in the
nucleus, cytoplasm, and particularly strongly at areas of
ruffles, shown as yellow in merge images (Fig. 6Diii,
6Fiii). All three human isoforms behave the same in the
presence of HSPC300 consistent with a conservation of
the interaction between Scar/WAVEs and HSPC300.
HA-Abi1 (Fig. 6Cii) strongly co localises with Myc-Scar 1
SHD (yellow, Fig 6Ciii), in unidentified punctate spots
(Fig 6Ci). Myc-Scar 2 SHD (Fig. 6Ei) shows a similar co
localisation with Abi1 (Fig. 6Eii and 6iii), whilst Myc-Scar
3 SHD (Fig. 6Gi) shows partial co-localisation to Abi1
(Fig. 6Gii and 6iii). Although Myc-Scar3 SHD (Fig. 6Gi)
co-localises to the HA-Abi1 spots (Fig. 6Giii) to a lesser
extent than Scar/WAVE1 and 2 SHD, leaving some diffuse
staining in the cytoplasm and nucleus. Abi1 expression
affects the localisation of all three human Scar/WAVE iso-
forms in Cos7 cells, providing further evidence for a role
of the Scar/WAVE complex in regulation of the activity
and localisation of Scar/WAVE proteins. The staining pat-
tern seen for overexpressed HA-Abi1 (Fig. 6Aii, Cii, Eii and
6Gii) does not strongly correlate with the cellular localisa-
tion of endogenous Abi1 (Fig. 5Cii). Although the punc-
tuate staining pattern seen in cells over-expressing Abi1
has been described as being characteristic of the reticu-
lovesicular system (Ziemnicka-Kotula, 1998), it is also
possible that these spots are protein aggregates induced by
overexpression of Abi1. The relocalisation of Scar/
WAVE1, 2 and 3 SHDs to these vesicles or aggregates may
or may not be biologically important, but it does demon-
strate the possibility that Abi1 can affect Scar/WAVE pro-
tein localisation in cells.
Discussion
We show that Abi1 and HSPC300 interact with three
human Scar/WAVE isoforms, via the Scar Homology
Domain. Conservation of Abi1 binding between all three
Scar/WAVEs is indicative of the association of the "Scar/
WAVE complex" with all three isoforms, as Abi1 seems to
be the link between Scar/WAVE and NckAP1 and SRA-1/
PIR121 in previous reports [30,31]. Association of the
complex with all three Scar/WAVE proteins is a possibil-
ity, as all the complex members are widely expressed
throughout the body and seem to be found in all tissues
where a Scar/WAVE protein is expressed [26,60].
Little is known about the role of Scar/WAVE3 in cells.
Expression of the mammalian Scar/WAVE3 gene is largely
limited to the brain and lung with relatively little expres-
sion in other adult tissues [9,32,56]. The major suggestion
has been a role in lamellipodial and filopodial protrusion
indicated by localisation in neuronal growth cones and
interaction with the Arp2/3 complex [9,57]. Association
with a Abi1-NckAP1-SRA1 does indicate a further poten-
tial role for Scar/WAVE3 in lamellipodial protrusion given
the requirement for these proteins in the ruffling process
[31,36]. Scar/WAVE3 is also implicated as a potential
tumour suppressor protein in some ganglioneuroblasto-
mas when the gene is down-regulated [56].
The role of interaction of HSPC300 with the Scar/WAVE3
complex is unknown. Loss of function of the brk1 gene
product, the Maize homologue of HSPC300, causes aber-
rations in cellular morphology and filamentous actin dis-
tribution of leaf epidermal cells [24,25]. This could
indicate a role in regulating the localisation of actin
polymerisation machinery, but this idea awaits further
testing. HSPC300 is also implicated in the frequency of
occurrence of renal cell carcinoma [26].
Association of all three Scar/WAVE isoforms with an Abi-
NckAP1-SRA1 complex may show that there is some func-
tional redundancy between Scar/WAVE family members
but data from mice deficient in a Scar/WAVE isoform indi-
cates that Scar/WAVE1 and 2 do not have completely over-
lapping functions [37,38,57,61]. The identification of
specific binding partners for Scar/WAVE1, such as WRP,BMC Cell Biology 2005, 6:11 http://www.biomedcentral.com/1471-2121/6/11
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Cellular localisation of Scar3 Figure 5
Cellular localisation of Scar3. C2C12 cells were stained with anti-Scar/WAVE3, anti-Arp3, anti-Abi1 and fluorescently labelled 
phalloidin to investigate the cellular localisation of endogenous proteins. (A) C2C12 cells stained with (i) anti-Scar/WAVE3 
(green), (ii) phalloidin (red) (iii) reveal co-localisation of Scar/WAVE3 with cortical polymerised actin in membrane ruffles. Scar/
WAVE3 also colocalises with other areas enriched in polymerised actin, but not stress fibres. (B) Co-staining with (i) anti-Scar/
WAVE3 and (ii) anti-Arp3 reveals co-localisation of Scar/WAVE3 (green) with the Arp2/3 complex (red) at protruding areas of 
the cell membrane. (C) Cells stained with (i) anti-Scar/WAVE3 and (ii) anti-Abi1. (iii) Scar/WAVE3 (green) co-localises with 
Abi1 (red) in some areas of membrane protrusion. A (i), B (i), and C (i) all show a cytoplasmic and perinuclear and cytoplasmic 
pool of Scar/WAVE3, with enrichment at areas of lamellipodial protrusion. B (ii) and C (ii) show similar patterns of staining for 
Arp3 and Abi1. Scale bars are equal to 20 µm in all pictures.
A Merge phalloidin (Red) anti-Scar3 (Green)
i iii ii
B anti-Scar3 (Green) anti-Arp3 (Red) Merge
i iii ii
C anti-Abi1 (Red) anti-Scar3 (Green) Merge
i ii iiiBMC Cell Biology 2005, 6:11 http://www.biomedcentral.com/1471-2121/6/11
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Cellular localization of Abi1, HSPC300, and the Scar homology domain Figure 6
Cellular localization of Abi1, HSPC300, and the Scar homology domain. Transfected Cos cells were stained with a monoclonal 
anti-Myc antibody and polyclonal anti-HA antibodies to detect over-expressed proteins. (A) Cos7 cells were co-transfected 
with (i) HA-HSPC300, (ii) HA-Abi1, (iii) Myc-Scar1 SHD, (iv) Myc-Scar2 SHD, or (v) Myc-Scar3 SHD to examine localization of 
these proteins. HSPC300, and all three SHDs localise in a diffuse cytoplasmic pool with some enrichment at protrusive edges 
of cells. Abi1 is not detected at the edges of cells, but appears in vesicle-like spots throughout the cytoplasm. (B) Cos7 cells 
were co-transfected with Myc-Scar1 SHD (i) and HA-HSPC300 (ii) shown as red and green respectively in a merged image (iii). 
Scar1-SHD and HSPC300 exhibit the same diffuse staining throughout the cytoplasm but also co-localize at protruding edges of 
cells. (C) Cos7 cells were co-transfected with Myc-Scar1 SHD (i) and HA-Abi1 (ii). (iii) Shows a merge image with myc-Scar1 
SHD in red and HA-Abi1 in green. Scar1 SHD and Abi1 both colocalize to punctate spots similar to those seen for Abi1 alone. 
(D) Cos7 cells co-transfected with Myc-Scar2 SHD (i) and HA-HSPC300 (ii) shown as red and green respectively in a merge 
image (iii). Both Scar2 SHD and HSPC300 exhibit peri-nuclear staining and localization to protrusive edges of cells. (E) Cos7 
cells co-transfected with Myc-Scar2 SHD (i) and HA-Abi1 (ii). (iii) Scar2 SHD (red) and Abi1 (green) show co-localization to 
cytoplasmic spots and the edges of cells. (F) Cos7 cells co-transfected with (i) Myc-Scar3 SHD (red) and (ii) HA-HSPC300 
(green), in a merged image (iii). HSPC300 and Scar3 SHD show diffuse cytoplasmic staining with enrichment at protrusive 
edges of cells. (G) Cos7 cells co-transfected with (i) Myc-Scar3 SHD and (ii) HA-Abi1. (iii) In a merge image Abi1 (green) and 
Scar3 SHD (red) co-localize to punctate cytoplasmic spots and to the edges of lamellipodia. Scale bars in all panels are 20 µm.
B
Myc-Scar1 SHD HA-HSPC300 Merge
i ii iii
Merge Myc-Scar1 SHD HA-Abi1
i ii iii
C
Myc-Scar3 SHD HA-HSPC300 Merge
F
i ii iii
Myc-Scar3 SHD Merge HA-Abi1
i ii iii
G
Myc-Scar3 SHD
HA-HSPC300 HA-Abi1
Myc-Scar1 SHD Myc-Scar2 SHD
A
ii i
iii iv v
D
Myc-Scar2 SHD HA-Abi1 Merge
i ii iii
Myc-Scar2 SHD HA-HSPC300 Merge i ii iii
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BAD or the RII subunit of PKA suggests a potential for dif-
fering roles between Scar/WAVE proteins [62-64]. The
conservation of the Abi1-NckAP1-SRA1 complex between
three Scar/WAVE isoforms suggests that regulation of indi-
vidual Scar/WAVE proteins is likely to involve compo-
nents that we have not yet studied [37,57,58,61]. Other
proteins that associate with the complex may perform this
regulation, or tissue specificity may occur between the
complexes formed where differentially expressed related
proteins, such as Abi1 or 2, bind to alternative Scar/WAVE
isoforms with different affinities. Further study of the
Scar/WAVE family and associated proteins will be
required to fully understand the true roles and mecha-
nisms of function of these complexes in cells.
Conclusion
We conclude that Scar/WAVE3 is likely to participate in
similar signalling complexes to Scar/WAVE1 and 2 and
that the differences between these Scar/WAVE proteins is
likely to be at the level of tissue expression, differences in
affinity for certain binding partners and possibly interac-
tion with yet undiscovered binding partners.
Methods
Reagents and chemicals
All chemicals were purchased from Sigma-Aldrich, UK
unless otherwise specified. Antibodies were from the fol-
lowing sources: 9E10 anti-Myc monoclonal (Cancer
Research UK), 12CA5 anti-HA monoclonal (Cancer Reae-
arch UK), anti-Myc polyclonal 1:500 anti-HA polyclonal
(Santa Cruz), 1:500 anti-Scar/WAVE3 (Upstate), 1:100
anti-Abi1, or 1:100 anti-Scar/WAVE1 [65], anti-Abi1 (gift
from Giorgio Scita, Instituto Europeo di Oncologia,
Milan, Italy), HRP-conjugated secondary antibody anti-
mouse or anti-rabbit (Jackson labs), anti-Arp3 (Sigma
Israel), Goat anti-mouse or rabbit, FITC, TRITC, Alexa-488
or Alexa-546 Conjugates (Molecular Probes). The specifi-
city of the anti-Scar/WAVE3 antibody for Scar/WAVE3 has
been demonstrated by Oda and colleagues [47].
Vectors and cloning
HSPC300 and Abi1 expression vectors were created using
the Gateway Cloning system (Invitrogen). Open reading
frames for HSPC300, and Abi1, derived from I.M.A.G.E.
clones 4519512 (HSPC300) and 4158413 (Abi1) (UK-
Human Genome Resource Centre, Babraham), were
amplified by PCR and ligated into the pENTR-Topo entry
vector (Invitrogen). N-terminally HA- and Myc- tagged
HSPC300, and Abi1, were created in pRK5 DEST-Myc or
pRK5 DEST-HA Gateway destination vectors by recombi-
nation from entry vectors. pRK5 DEST-Myc or pRK5
DEST-HA were created by ligation of the Gateway Vector
Conversion System (Invitrogen) reading frame A cassette
into pRK5-myc or pRK5-HA cut with SmaI. Scar/WAVE1,
Scar/WAVE2, and Scar/WAVE3 full length and deletion
constructs were created by PCR and cloned into pRK5-
myc or pGEX4T-2. Scar/WAVE-1 constructs were derived
from KIAA00429[7]; Scar/WAVE2 constructs were derived
from pDSRed Scar2, a kind gift from Giorgio Scita (Inno-
centi et al., 2004); Scar/WAVE3 constructs were derived
from pcDNA Scar3, a kind gift from John Scott, Portland,
U.S.A. L61 Cdc42-pGex2T and IRSp53-pRK5-Myc were a
gift from Alan Hall (LMCB, London) [54]. IRSp53 was
subcloned into pGex4T-2 using BamH1 and EcoR1 restric-
tion sites. For Yeast Two-Hybrid analyses, Abi1 and
HSPC300 were fused in-frame to the C-terminus of the
GAL4 DNA-binding domain in pYTH9. Myc-tagged Scar/
WAVE1 deletion constructs have been previously
described[7]. Scar1 deletion mutants (described in Addi-
tional file 1) were fused to the C-terminus of the GAL4
activation domain in pACT-II [66]. Yeast 2-hybrid analy-
ses were performed as previously described [66].
Cell culture, transfection, and lysis
Cos 7 and C2C12 cells were grown in DMEM plus 10%
Foetal Calf Serum and antibiotics. Transfections were per-
formed using Genejuice transfection reagent (Novagen)
following the manufacturers instructions. Cell lysis was
performed from confluent cells in a 1% Triton X-100 lysis
buffer (1% Triton X-100, 50 mM Tris-HCl pH 7.5, 150
mM NaCl,, 1 mM EDTA, 10% Glycerol, 1 mM PMSF, and
1 µg/ml each of chymostatin, aprotinin, leupeptin, and
pepstatin). Lysates were cleared by centrifugation and
equalised to 1 mg/ml total protein concentration.
Preparation of mouse brain extract
Mouse brains were homogenised on ice in 2 µl of 1% Tri-
ton X-100 lysis buffer per mg of tissue using a fine gauge
needle. Homogenates were centrifuged once for 10 min-
utes at 13,000 rpm in a microcentrifuge, then for 30 min-
utes at 100,000 g in a Beckmann TLA-100.2 rotor.
Supernatants were equalised to 1 mg/ml total protein con-
centration with 1% Triton X-100 lysis buffer.
Immunoprecipitations
Lysates or brain extracts (500 µg of total protein) were
incubated with 30 µl bed volume of pre-washed protein G
beads (Cancer Research UK) for 1 hour, designated beads
minus antibody controls. Beads were precipitated and
supernatants removed. 5 µg of antibody monoclonal
9E10 anti-myc, 12CA5 anti-HA, Rabbit anti-Scar/WAVE3,
or Mouse anti-Abi1 or an irrelevant control antibody (rab-
bit or mouse anti-myc) was added to the supernatant and
incubated for 1 hour, before the addition of 30 µl bed vol-
ume of pre-washed protein G beads, designated beads
plus antibody, for 1 hour. Beads were precipitated, and
the supernatant removed. Beads were washed 3 times in
30-fold bed volume of lysis buffer. Beads were resus-
pended in an equal volume of 2× SDS-PAGE loadingBMC Cell Biology 2005, 6:11 http://www.biomedcentral.com/1471-2121/6/11
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buffer [67]. 10 µl of beads sample and supernatant was
analysed by SDS-PAGE and western blotting.
GST-production and pull downs
GST-fusion proteins were expressed in BL21 E.coli induced
for 3 hours with 0.2 mM IPTG, or 15 hours at 25°C for
GST-IRSp53. Cells were spun down and sonicated in 1 ml
of 1% Triton PBS (1% Triton X-100, PBS pH 7.5, 1 mM
PMSF, and 1 µg/ml each of chymostatin, leupeptin, apro-
tinin, and pepstatin) per 100 ml bacterial culture. GST
fusion proteins were batch purified on 100 µl
Glutathione-s-agarose (Sigma) per 100 ml culture and
washed 5 times with 10-fold bed volume of sonication
buffer. Beads were resuspended in an equal volume of 1%
Triton lysis buffer. SDS-PAGE analysis and coomasie
staining were used to qualify GST fusion proteins. 500 µg
total protein of transfected Cos7 cell lysate was incubated
with GST-fusion protein or GST alone for 1 hour. Beads
were precipitated, lysates removed and the beads were
washed 3 times in 1% Triton lysis buffer. Beads were
resuspended in and equal volume of 2× SDS-PAGE load-
ing buffer. Samples were analysed by SDS-PAGE and west-
ern blotting.
SDS-PAGE and Western blotting
Proteins were separated by SDS-PAGE and transferred
onto nitrocellulose membrane by western blotting. Blots
were saturated with 5% dried milk in PBS 0.2% Tween-20,
probed with 1:500 9E10 anti-Myc monoclonal, 1:500
12CA5 anti-HA monoclonal, 1:500 anti-Myc polyclonal
1:500 anti-HA polyclonal, 1:500 anti-Scar/WAVE3, 1:100
anti-Abi1, or 1:100 anti-Scar/WAVE1 primary antibody in
2.5% BSA 0.2% Tween-20 PBS followed by 1:10'000 dilu-
tion of HRP-conjugated secondary antibody diluted in
0.2% Tween-20 PBS. Bound secondary antibody was visu-
alised using SuperSignal (Pierce) according to the manu-
facturers instructions.
Immunofluorescence microscopy
Cells cultured on glass coverslips were fixed in 4% para-
formaldehyde and permeabilized with 0.1% Triton PBS.
Cells were stained with 1:200 Rb anti-HA polyclonal,
1:200 12CA5 anti-HA monoclonal, 1:200 9E10 anti-myc
monoclonal, 1:100 anti-Scar\WAVE3, 1:200 monoclonal
anti-Arp3, or 1:25 anti-Abi1 primary antibodies diluted in
1% BSA PBS. Secondary antibodies used were Goat anti-
mouse or rabbit, FITC, TRITC, Alexa-488 or Alexa-546
Conjugates at 1:200 dilution in 1% BSA PBS. Filamentous
actin was visualised using Alexa-546 conjugated phalloi-
din (Molecular Probes) diluted 1:500 in 1% BSA PBS.
Slides were viewed using a BioRad MRC100 confocal laser
scanning microscope. For endogenous Scar/WAVE3 label-
ling, it was important to test which cell lines expressed
Scar/WAVE3. Among the following cell lines: NIH 3T3,
N1E 115 neuroblastoma, N19 neuroblastoma, PC6 neu-
ronal precursor, J774.A1 bone marrow macrophage, RAW
264.7 alveolar macrophage and C2C12 myoblast, we
found that only C2C12 expressed endogenous Scar/
WAVE3 by western blotting of whole cell lysates (M. Var-
tiainen, unpublished results). We thus used C2C12 for
localisation of endogenous Scar/WAVE3 protein.
Abbreviations
GST glutathione-S-transferase, WH2 WASP-homology 2,
A acidic sequence motif, SHD Scar homology domain,
NckAP1 Nck-associated protein 1, HSPC300
haematopoeitc stem/progenitor cell protein, Abi 2 abel-
son tyrosine kinase interactor 2
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Additional File 1
Characterization of HSPC300 and Abi1 binding domain of Scar/
WAVE1.  (A) Schematic representation of the domain architecture of 
Scar/WAVE family proteins and the deletion constructs used in these 
experiments.  Numbers indicate start or end point of Scar/WAVE1 dele-
tion mutants in amino acid residue position.  Start/End points for Scar/
WAVE2 deletion mutants are FL = 498, delta A = 456, SPW = 455, SP 
= 435, SB = 245, SHD = 170, BPWA = 171, PWA = 246.  Start/End 
points for Scar/WAVE3 deletion mutants are FL = 499, delta A = 488, 
SPW = 457, SP = 439, SB = 238, SHD = 171, BPWA = 172, PWA = 
239.  FL; Full length.  SHD; Scar Homology Domain.  B; Basic Rich 
Region.  PRR; Proline rich region.  W; Wiskott Homology 2 domain.  C; 
Central or connecting region.  A; Acidic Rich Region.  (B) Co-immuno-
precipitation of HA-Abi1 with Myc-Scar/WAVE deletion constructs.  (C) 
Co-immunoprecipitation of HA-Abi1 or HA-HSPC300 respectively with 
Myc-Scar/WAVE deletion constructs.  Protein G beads were used to 
immunoprecipitate protein from transiently transfected Cos 7 fibroblasts 
before (-Ab) and after addition (+Ab) of an anti-Myc (9E10) monoclonal 
antibody.  Bead bound fractions and supernatants (Sup) were analysed by 
SDS-PAGE followed by immunoblotting.  Blots were probed with an anti-
HA polyclonal antibody for the presence of HA-Abi1 or HA-HSPC300 in 
immunoprecipitated complexes.
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